Curative effect analysis of endoscopic revision surgery combined with middle turbinate resection for refrac-tory rhinosinusitis
Objective To investigate the effect of revision endoscopic sinus surgery(RESS)com-bined with middle turbinate resection(MT)in the treatment of refractory rhinosinusitis(RRS)pa-tients and their postoperative recurrence.Methods A total of 200 RRS patients treated in our hospital from January 2019 to January 2021 were selected as the research subjects,and randomly divided into observation group and control group,with 100 cases in each group.The control group received endo-scopic sinus surgery(ESS)treatment,and the observation group received RESS combined with MT treatment.The surgical effect,clinical symptom scores before and after surgery,nasal airway resist-ance(NAR),olfactory function,nasal endoscopy quantitative evaluation score(Lund-Kennedy),in-flammatory factor levels[interleukin-5(IL-5),interleukin-8(IL-8),C-reactive protein(CRP)],com-plication rate were compared between the two groups.After 6 months of follow-up,the recurrence rates of the two groups were calculated.Results The excellent and good rate of surgery in the control group was 83.00％,the complication rate was 16.00％,and the recurrence rate at 6 months after sur-gery was 14.46％.The corresponding rates in the observation group were 97.00％,3.00％,and 1.03％,respectively.There were significant differences between the two groups(P＜0.05).Com-pared with the control group,the scores of olfactory dysfunction,pus discharge,nasal congestion,pain,NAR,olfactory function,Lund-Kennedy in the observation group were lower at 3 months after operation,and the differences were statistically significant(P＜0.05).The levels of serum IL-5,CRP,IL-8 in the observation group were lower,and the differences were statistically significant(P＜0.05).Conclusion Compared with ESS,RESS combined with MT has more advantages in impro-ving surgical effect,clinical symptoms,olfactory and nasal mucosa function,reducing NAR,reducing complications,recurrence rate and inflammatory response in the treatment of RRS patients.
NETL
NSTL
万方数据
维普
